Showing results (461-470 of 486) with videos related to
Sort By:
Pageof 49
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.Clinical and Experimental Immunology|July 17, 2018
Porphyromonas gingivalis in the tongue biofilm is associated with clinical outcome in rheumatoid arthritis patientsF Ceccarelli, G Orrù, A Pilloni, et al.Arthritis Research & Therapy|July 3, 2019
Anti-D4GDI antibodies activate platelets in vitro: a possible link with thrombocytopenia in primary antiphospholipid syndromeC Barbati, L Stefanini, T Colasanti, et al.International Journal of Immunopathology and Pharmacology|June 13, 2013
Vascular endothelial growth factor (VEGF), mast cells and inflammationY B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.Arthritis Research & Therapy|January 31, 2019
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugsM Vomero, V Manganelli, C Barbati, et al.International Journal of Immunopathology and Pharmacology|September 27, 2013
Impact of capsaicin on mast cell inflammationS Frydas, G Varvara, G Murmura, et al.Biomedical Optics Express|October 25, 2021
Student becomes teacher: training faster deep learning lightweight networks for automated identification of optical coherence tomography B-scans of interest using a student-teacher frameworkJulia P Owen, Marian Blazes, Niranchana Manivannan, et al.Journal of Biological Regulators and Homeostatic Agents|April 14, 2010
Impact of RANTES, MCP-1 and IL-8 in mast cellsM L Castellani, M A De Lutiis, E Toniato, et al.Journal of Biological Regulators and Homeostatic Agents|July 9, 2013
Role of vitamins D, E and C in immunity and inflammationY B Shaik-Dasthagirisaheb, G Varvara, G Murmura, et al.Journal of Viral Hepatitis|December 16, 2016
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and olderF Conti, S Brillanti, F Buonfiglioli, et al.Pageof 49